This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

Pancreatic cancer accounts for about 8% of all cancer deaths. Ben Sasse says he expects to be one of them. Here's what to ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

The American Cancer Society projected for 2025 that there would be over 154,000 new cases of colorectal cancer and 52,900 ...

A study finds severe valvular heart disease in 7.2% of patients with cancer undergoing echocardiography, with valvular ...

Breast cancer in young women is driven by more aggressive molecular and epidemiologic features and requires age-specific, multidisciplinary management that balances oncologic goals with fertility ...

Your liver cells are forgetting how to do their jobs under dietary stress. Here's how that signals cancer risk years before ...

Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were most notable in people with alopecia areata and Sjögren syndrome. Findings ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...